Verrica Pharmaceuticals Inc. (VRCA) ROI
- 2025-12-31: ROI -72.29%.
- 2025-09-30: ROI -152.69%.
- 2025-06-30: ROI -245.86%.
- 2025-03-31: ROI -299.22%.
Complete source-backed roi history.
- Available history
- 2022-12-31 to 2025-12-31
- Data captured
Historical ROI
| Date | ROI |
|---|---|
| 2025-12-31 | -72.29% |
| 2025-09-30 | -152.69% |
| 2025-06-30 | -245.86% |
| 2025-03-31 | -299.22% |
| 2024-12-31 | -224.83% |
| 2023-12-31 | -106.96% |
| 2022-12-31 | -61.17% |
Annual ROI
| Date | ROI |
|---|---|
| 2025-12-31 | -72.29% |
| 2024-12-31 | -224.83% |
| 2023-12-31 | -106.96% |
| 2022-12-31 | -61.17% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |